{Atacicept | VT-001: A Novel Therapeutic Atacicept, also known as the VT-001 agent, represents a compelling advance in therapeutic science. This innovative substance functions as a decoy molecule, effectively neutralizing the activity of TNFSF-13 , a key component in B-cell longevity and antibody production. Initial clinical studies have shown